Andréa Silvestre de Sousa

Development and Validation of a Risk Score for Predicting Death in Chagas' Heart Disease

Anis Rassi, Anis Rassi, William C. Little et al. · New England Journal of Medicine · 2006 · 642 citations · Full text

Medicine, Cardiology, Health Sciences +17

Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19

Renato D. Lópes, Ariane Vieira Scarlatelli Macedo, Pedro Gabriel Melo de Barros e Silva et al. · JAMA · 2021 · 381 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +6

Prognostic Value of QT Interval Parameters for Mortality Risk Stratification in Chagas’ Disease

Gil F. Salles, Sérgio Salles Xavier, Andréa Silvestre de Sousa et al. · Circulation · 2003 · 132 citations · Full text

Medicine, Cardiology, Clinical Cardiology +16

Acute Chagas disease in Brazil from 2001 to 2018: A nationwide spatiotemporal analysis

Emily Ferreira Santos, Ângelo Antônio Oliveira Silva, Leonardo Maia Leony et al. · PLoS neglected tropical diseases · 2020 · 109 citations · Full text

Veterinary Medicine, Infectious Diseases, Population Health Sciences +17

Safety of benznidazole use in the treatment of chronic Chagas' disease

Alejandro Marcel Hasslocher‐Moreno, Pedro Emmanuel Alvarenga Americano do Brasil, Andréa Silvestre de Sousa et al. · Journal of Antimicrobial Chemotherapy · 2012 · 94 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14